Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Oaktree Acquisition III Life Sciences's earnings per share without non-recurring items for the
three
months ended in Jun. 2026 was $0.07.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2026 was $0.29.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
OACC's 3-Year EPS without NRI Growth Rate is not ranked *
in the Diversified Financial Services industry.
Industry Median: 19.4 * Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
Oaktree Acquisition III Life Sciences (NAS:OACC) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Oaktree Acquisition III Life Sciences EPS without NRI Related Terms
Oaktree Acquisition III Life Sciences EPS without NRI Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oaktree Acquisition III Life Sciences EPS without NRI Chart
Oaktree Acquisition III Life Sciences Annual Data
Trend
Dec24
Dec25
EPS without NRI
0.00
0.30
Oaktree Acquisition III Life Sciences Quarterly Data
OACC vs DMAA, FACT, NTWO: EPS without NRI Comparison
For the Shell Companies subindustry, Oaktree Acquisition III Life Sciences's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oaktree Acquisition III Life Sciences PE Ratio without NRI vs Diversified Financial Services Industry
For the Diversified Financial Services industry and Financial Services sector, Oaktree Acquisition III Life Sciences's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Oaktree Acquisition III Life Sciences's PE Ratio without NRI falls into.
Oaktree Acquisition III Life Sciences EPS without NRI Calculation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.29
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oaktree Acquisition III Life Sciences (OACC) has a EPS without NRI of $0.29 as of Jun. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Oaktree Acquisition III Life Sciences and its competitors. According to the industry distribution chart, Oaktree Acquisition III Life Sciences ranks #999999 out of 167 companies in the Diversified Financial Services industry.
Is Oaktree Acquisition III Life Sciences' EPS without NRI too high?
Oaktree Acquisition III Life Sciences' current EPS without NRI is $0.29. The Diversified Financial Services industry median EPS without NRI is 19.40. Oaktree Acquisition III Life Sciences' value of $0.29 is 98.5% below this industry median. Based on the distribution chart, Oaktree Acquisition III Life Sciences ranks #999999 out of 167 companies in the Diversified Financial Services industry, which is in the bottom quartile relative to peers. Overall, Oaktree Acquisition III Life Sciences has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Oaktree Acquisition III Life Sciences' EPS without NRI compare to DMAA and FACT?
According to the Diversified Financial Services industry distribution chart, Oaktree Acquisition III Life Sciences ranks #999999 out of 167 companies for EPS without NRI. This places Oaktree Acquisition III Life Sciences in the lower half of its industry. The industry median EPS without NRI is 19.40. Oaktree Acquisition III Life Sciences' value of $0.29 is 98.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Diversified Financial Services company?
The median EPS without NRI among Diversified Financial Services companies is 19.40, based on 167 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Oaktree Acquisition III Life Sciences's current EPS without NRI of $0.29 is 98.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Oaktree Acquisition III Life Sciences and its competitors. For the Diversified Financial Services industry, the median EPS without NRI is 19.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oaktree Acquisition III Life Sciences's current EPS without NRI is $0.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oaktree Acquisition III Life Sciences stock overvalued right now?
Oaktree Acquisition III Life Sciences (OACC) has a current EPS without NRI of $0.29. The current EPS without NRI is $0.29 and 98.5% below the Diversified Financial Services industry median of 19.40. Oaktree Acquisition III Life Sciences' overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Oaktree Acquisition III Life Sciences (OACC), the current EPS without NRI is $0.29 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OACC has been successfully added to your 
